Radiation Oncology/Esophagus/RTOG Esophagus

Esophageal Cancer: RTOG OPEN TRIALS
Number Title
04-36 A Phase III Trial Evaluating The Addition Of Cetuximab To Paclitaxel, Cisplatin, And Radiation For Patients With Esophageal Cancer Who Are Treated Without Surgery


Esophageal Cancer: RTOG CLOSED TRIALS
Number Title Publication
02-46 A Phase II Study Of A Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus ASTRO Abstract
01-13 Non-Operative Therapy Of Local-Regional Carcinoma Of The Esophagus: A Randomized Phase II Study Of Two Paclitaxel-Based Chemoradiotherapy Regimens PMID 18574157
97-16 CALGB 9781: A Prospective Randomized Phase III Trial Comparing Trimodality Therapy (Cisplatin, 5-FU, Radiotherapy, And Surgery) To Surgery Alone For Esophageal Cancer PMID 18309943
94-05 A Phase III Intergroup Randomized Comparison Of Combined Modality Therapy For Carcinoma Of The Esophagus: High Dose Vs. Conventional Dose Radiation Therapy PMID 11870157
92-07 A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus PMID 10699886
90-12 Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus PMID 10078631
85-01 Phase III trial of combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus PMID 10235156
This article is issued from Wikibooks. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.